Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Hodgkin Disease × Plasma cell × Clear all

Phase

Phase 2 119 Phase 1 80 Phase NA 53 Phase 1/2 40 Phase 3 26 Phase EARLY_PHASE1 2 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 5 Plasma cell 1 Other hematologic neoplasm 1 Myeloid 1

Conditions

Multiple Myeloma 27 Neoplasms, Plasma Cell 8 Neoplasms 6 Lymphoma 5 Leukemia 5 Infections 4 Hematologic Neoplasms 4 Thyroid Carcinoma, Anaplastic 2 Thyroid Cancer, Papillary 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Neoplasms by Site 2 Neoplasms by Histologic Type 2 Myelodysplastic Syndromes 2 Lymphoma, Non-Hodgkin 2 Laryngeal Neoplasms 2 Granuloma, Plasma Cell 2 Glioma 2 Erdheim-Chester Disease 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Sarcoma, Synovial 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Perivascular Epithelioid Cell Neoplasms 1 Neurofibrosarcoma 1 Nerve Sheath Neoplasms 1 Nephrotic Syndrome 1 Neoplasm Metastasis 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01085058 2010-03-11

CU01

WiSP Wissenschaftlicher Service Pharma GmbH

Phase 2/3 Completed

LymphoidPlasma cell

Hodgkin Disease, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡